Active

CLONEVAX

Switched

BE0874375915

Rechtspersoon Private limited company 1 establishment

Leernsesteenweg 173, 9800 Deinze Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

21 year, 3 months

Financials

Financial year 2024

Gross margin

€ 18,843

▲ 58% vs 2023

Profit

Growing

€ 16,271

▲ 46% vs 2023

Debts

Low

€ 49,592

▲ 13% vs 2023

CLONEVAX from Deinze, company number BE0874375915, closed financial year 2024 with a result of € 16,271 after tax. For that financial year CLONEVAX recorded a gross margin of € 18,843 and equity of € 326,944. Compared with financial year 2023, the result moved from € 11,128 to € 16,271. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2025.

What happened at CLONEVAX?

What happened at CLONEVAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: profit of € 16,271 (▲ 46% vs 2023). Source: NBB ↗
  • WIM DE MAERTELAERE became a director. NBB
  • New establishment in Deinze. KBO
  • Start of the company according to the CBE. KBO

In short

From € 10,095 profit in 2022 to € 16,271 profit in 2024.

Paid € 21,776 in corporate taxes since 2022.

Best year ever: 2024, with € 16,271 profit.

A new publication or filing at CLONEVAX? We notify you, reason included.

Follow CLONEVAX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

WIM DE MAERTELAERE
CLONEVAX

Behind CLONEVAX is WIM DE MAERTELAERE.

See the full network in the app

Directors

According to the 2024 annual accounts

WIM DE MAERTELAERE

bestuurder

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Leernsesteenweg 173 box E

9800 Deinze

2.147.598.113

Edekestraat 89

9800 Deinze

Active since 24 June 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0874.375.915
VAT number
BE 0874.375.915
Registered office
Leernsesteenweg 173 bus E, 9800 Deinze
Names & denominations
CLONEVAX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Opening faillissement
Start date
30 May 2005
Peppol
Active · Active since 3 Feb 2026
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computeradviesbureaus

Computerconsultancy-activiteiten

Frequently asked questions

What is the enterprise number of CLONEVAX?
The enterprise number of CLONEVAX is BE0874375915.
What is the address of CLONEVAX?
The registered office of CLONEVAX is located at Leernsesteenweg 173 box E, 9800 Deinze.
When was CLONEVAX founded?
CLONEVAX was founded on 30 May 2005.
What is the main activity of CLONEVAX?
The main activity of CLONEVAX is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does CLONEVAX have a website?
No website is currently known for CLONEVAX.
How much profit did CLONEVAX make in 2024?
CLONEVAX posted a profit after taxes of € 16,271 in financial year 2024.
What is the revenue of CLONEVAX?
As a small company, CLONEVAX is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 18,843.
Where can I find the annual accounts of CLONEVAX?
CLONEVAX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of CLONEVAX?
According to the 2024 annual accounts, the directors of CLONEVAX are: WIM DE MAERTELAERE.
Who owns CLONEVAX?
Behind CLONEVAX is WIM DE MAERTELAERE.